SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Wortmann S.)
 

Sökning: WFRF:(Wortmann S.) > Expanding the pheno...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006492naa a2200817 4500
001oai:gup.ub.gu.se/309391
003SwePub
008240528s2021 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:91923fb2-2551-4bc0-b6e5-b9e54ab67190
009oai:prod.swepub.kib.ki.se:147892867
024a https://gup.ub.gu.se/publication/3093912 URI
024a https://doi.org/10.1002/acn3.514702 DOI
024a https://lup.lub.lu.se/record/91923fb2-2551-4bc0-b6e5-b9e54ab671902 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1478928672 URI
040 a (SwePub)gud (SwePub)lud (SwePub)ki
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Hikmat, O.u Haukeland University Hospital,University of Bergen4 aut
2451 0a Expanding the phenotypic spectrum of BCS1L-related mitochondrial disease
264 c 2021-10-18
264 1b Wiley,c 2021
520 a Objective: To delineate the full phenotypic spectrum of BCS1L-related disease, provide better understanding of the genotype-phenotype correlations and identify reliable prognostic disease markers. Methods: We performed a retrospective multinational cohort study of previously unpublished patients followed in 15 centres from 10 countries. Patients with confirmed biallelic pathogenic BCS1L variants were considered eligible. Clinical, laboratory, neuroimaging and genetic data were analysed. Patients were stratified into different groups based on the age of disease onset, whether homozygous or compound heterozygous for the c.232A>G (p.Ser78Gly) variant, and those with other pathogenic BCS1L variants. Results: Thirty-three patients were included. We found that growth failure, lactic acidosis, tubulopathy, hepatopathy and early death were more frequent in those with disease onset within the first month of life. In those with onset after 1 month, neurological features including movement disorders and seizures were more frequent. Novel phenotypes, particularly involving movement disorder, were identified in this group. The presence of the c.232A>G (p.Ser78Gly) variant was associated with significantly worse survival and exclusively found in those with disease onset within the first month of life, whilst other pathogenic BCS1L variants were more frequent in those with later symptom onset. Interpretation: The phenotypic spectrum of BCS1L-related disease comprises a continuum of clinical features rather than a set of separate syndromic clinical identities. Age of onset defines BCS1L-related disease clinically and early presentation is associated with poor prognosis. Genotype correlates with phenotype in the presence of the c.232A>G (p.Ser78Gly) variant.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Medicinsk genetik0 (SwePub)301072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medical Genetics0 (SwePub)301072 hsv//eng
653 a lethal metabolic-disorder
653 a complex iii deficiency
653 a gracile syndrome
653 a iron-overload
653 a bcs1l gene
653 a mutations
653 a protein
653 a mechanism
653 a Neurosciences & Neurology
700a Isohanni, P.u University of Helsinki4 aut
700a Keshavan, N.u Great Ormond Street Hospital,UCL Institute of Child Health4 aut
700a Ferla, M. P.u Wellcome Trust Centre for Human Genetics4 aut
700a Fassone, E.u UCL Institute of Child Health4 aut
700a Abbott, M. A.u University of Massachusetts Chan Medical School,UCL Institute of Child Health4 aut
700a Bellusci, M.u 12 de Octubre University Hospital4 aut
700a Darin, Niklas,d 1964u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics,Queen Silvia Children’s Hospital4 aut0 (Swepub:gu)xdarin
700a Dimmock, D.u Rady Children’s Institute for Genomic Medicine4 aut
700a Ghezzi, D.u University of Milan,Carlo Besta Neurological Institute, IRCCS4 aut
700a Houlden, H.u University College London4 aut
700a Invernizzi, F.u Carlo Besta Neurological Institute, IRCCS4 aut
700a Jaman, N. B. K.u Karolinska Institute,Karolinska University Hospital4 aut
700a Kurian, M. A.4 aut
700a Morava, E.u Mayo Clinic Minnesota,University Hospitals Leuven4 aut
700a Naess, K.4 aut
700a Ortigoza-Escobar, J. D.u Biomedical Network on Rare Diseases (CIBERER)4 aut
700a Parikh, S.u Cleveland Clinic Foundation4 aut
700a Pennisi, A.u Necker-Enfants Malades Hospital4 aut
700a Barcia, G.u Necker-Enfants Malades Hospital4 aut
700a Tylleskar, K. B.u Haukeland University Hospital4 aut
700a Brackman, D.u Haukeland University Hospital4 aut
700a Wortmann, S. B.u Radboud University Medical Center,Paracelsus Private Medical University of Salzburg4 aut
700a Taylor, J. C.u Wellcome Trust Centre for Human Genetics4 aut
700a Bindoff, L. A.u University of Bergen,Haukeland University Hospital4 aut
700a Fellman, Vinetau Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Folkhälsan Research Center,University of Helsinki4 aut0 (Swepub:lu)pedi-vfe
700a Rahman, S.u UCL Institute of Child Health,Great Ormond Street Hospital4 aut
710a Haukeland University Hospitalb University of Bergen4 org
773t Annals of Clinical and Translational Neurologyd : Wileyg 8:11, s. 2155-2165q 8:11<2155-2165x 2328-9503
856u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51470
856u http://dx.doi.org/10.1002/acn3.51470x freey FULLTEXT
8564 8u https://gup.ub.gu.se/publication/309391
8564 8u https://doi.org/10.1002/acn3.51470
8564 8u https://lup.lub.lu.se/record/91923fb2-2551-4bc0-b6e5-b9e54ab67190
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:147892867

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy